Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sentinel nodes in gynecologic malignancies.

P T Ramirez1, C Levenback

  • 1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Current Opinion in Oncology
|September 14, 2001
PubMed
Summary

Sentinel node identification using radioactive tracers and blue dyes helps reduce extensive surgeries for gynecologic cancers. Advanced techniques improve the accuracy of detecting cancer spread, minimizing unnecessary procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.

Gynecologic oncology·2023
Same author

Outcomes of enhanced recovery after surgery (ERAS) in gynecologic oncology - A systematic review and meta-analysis.

Gynecologic oncology·2021
Same author

Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with endometrial cancer: a meta-analysis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
Same author

Enhanced recovery after surgery (ERAS®) in gynecologic oncology - Practical considerations for program development.

Gynecologic oncology·2017

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gynecologic Oncology

Background:

  • Sentinel node biopsy is standard for breast cancer and melanoma.
  • Minimally invasive techniques are sought for gynecologic malignancies to reduce morbidity.
  • Current lymphadenectomy procedures can be extensive and associated with significant complications.

Purpose of the Study:

  • To evaluate the effectiveness of sentinel node identification in reducing lymphadenectomy for vulvar and cervical cancers.
  • To explore the role of novel diagnostic techniques in enhancing sentinel node analysis.
  • To decrease patient morbidity by avoiding unnecessary surgical interventions.

Main Methods:

  • Utilizing radioactive tracers and blue dyes for sentinel node identification.

Related Experiment Videos

  • Performing sentinel node biopsy in patients with vulvar and cervical carcinomas.
  • Applying advanced histopathologic ultrastaging, immunohistochemistry staining, and RT-PCR assays for enhanced detection.

    • Main Results:

    • Sentinel node identification shows potential to significantly decrease the number of patients requiring extensive lymphadenectomy.
    • The application of novel techniques increases the accuracy and detection rate of metastatic disease in sentinel nodes.
    • This approach may lead to less aggressive surgical management in early-stage disease.

    Conclusions:

    • Sentinel node identification is a viable strategy to reduce morbidity in gynecologic cancer surgery.
    • Advanced diagnostic methods improve the reliability of sentinel node biopsy.
    • This technique offers a more targeted approach, potentially sparing patients from unnecessary radical lymphadenectomy.